BA/BE trial of Wosulin® N (100 IU/mL)
Phase 1
- Registration Number
- CTRI/2021/03/031985
- Lead Sponsor
- Wockhardt Bio AG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Subjects with normal health as determined by medical history, clinical examination and laboratory examinations within the clinically acceptable normal range.
Exclusion Criteria
- Hypersensitivity to Insulin or related class of drugs.
- History or presence of significant cardiovascular, pulmonary, hepatic, renal, gastrointestinal, endocrine, immunological, dermatological, neurological or psychiatric disease or disorder.
Study & Design
- Study Type
- BA/BE
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method